Welcome to our dedicated page for Ibex SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IBEX Limited (IBEX) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. As a Nasdaq-listed Bermuda company and emerging growth issuer, IBEX files a range of documents with the U.S. Securities and Exchange Commission that detail its operations, governance, and financial performance.
Key filings include Form 10-K and related annual reports, which present audited financial statements, risk factors, and management’s discussion of results for the fiscal year. Quarterly results and updates are frequently communicated through Form 8-K, where ibex furnishes press releases covering revenue, net income, adjusted net income, adjusted EBITDA, and earnings per share, as well as guidance ranges for future periods.
Investors can also review proxy materials such as the DEF 14A, which describe the board structure, director independence, committee composition, executive compensation programs, long-term incentive plans, and changes in status such as the transition away from controlled company exemptions. Other 8-K filings address governance developments, including the formation of a formal Nominating Committee and related board decisions.
Stock Titan enhances these filings with AI-powered summaries and explanations that highlight important sections, clarify technical language, and surface items that may matter to shareholders, such as governance changes, compensation plans, or capital allocation decisions. Real-time updates from EDGAR ensure that new IBEX filings, including Forms 3, 4, and 5 for insider transactions when available, appear promptly.
Use this page to explore IBEX’s historical and current SEC record, understand how management presents its strategy and performance, and quickly grasp the implications of lengthy documents through AI-generated insights.
IBEX Ltd Chief Executive Officer Robert Thomas Dechant reported equity compensation transactions in IBEX common shares. On February 6, 2026, he acquired 124,582 common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of this award vested on February 6, 2026, with additional thirds scheduled to vest on February 6, 2027 and February 6, 2028, subject to his continued service. On the same date, 18,988 shares were disposed of at $34.98 to cover taxes, leaving Dechant with 305,406 common shares held directly.
IBEX Ltd’s Chief Sales and CS Officer, Bruce Neil Dawson, reported equity awards and related tax withholding in company stock. On February 6, 2026, he acquired 82,519 common shares at $0 per share as a restricted stock award tied to an April 20, 2022 performance share grant that met revenue and EBITDA targets.
These shares vest in three equal parts: one-third vested on February 6, 2026, with additional thirds scheduled for February 6, 2027 and February 6, 2028, contingent on his continued service. On the same date, 12,246 common shares were disposed of at $34.98 per share to satisfy tax withholding on the vesting. After these transactions, he directly owned 77,034 common shares.
IBEX Ltd’s Chief People Officer, Inson Paul Joseph, reported equity compensation activity. On February 6, 2026, he acquired 25,180 IBEX common shares at $0 as a restricted stock award tied to an April 20, 2022 performance share grant based on revenue and EBITDA targets.
One-third of the award vested on February 6, 2026, with additional one‑third tranches scheduled for February 6, 2027 and February 6, 2028, subject to continued service. On the same date, 2,627 shares were sold at $34.98 to cover taxes upon vesting, leaving him with 27,469 common shares held directly.
IBEX Limited reports strong growth in its quarter ended December 31, 2025, with revenue of
Quarterly net income rose 31.8% to
Operating cash flow reached
IBEX Limited filed a current report to share that it has released financial results for its second fiscal quarter ended December 31, 2025. On February 5, 2026, the company issued a press release detailing these quarterly results, which is included as Exhibit 99.1. The report notes that this earnings information is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
IBEX Ltd’s Chief AI & Digital Officer has updated her reported shareholdings. The officer now reports direct beneficial ownership of 6,696 common shares. This amended filing corrects the prior holdings disclosure and explains how past equity awards and related tax share sales affect the total.
The explanation notes a November 8, 2024 grant of 3,521 restricted stock units, with 25% vesting on July 1, 2025 and annually thereafter. When the July 1, 2025 portion vested, 315 shares were sold for tax purposes, leaving 565 fully vested shares from this grant.
The filing also describes 490 fully vested performance stock units and a separate grant of 3,000 restricted stock units that vest 25% on September 16, 2026 and annually thereafter. Overall, the document primarily clarifies the structure and status of this executive’s equity-based compensation and current direct share ownership.
IBEX Ltd filed an initial ownership report for Chief AI & Digital Officer Michael Joseph Darwal. As of January 1, 2026, he beneficially owned 7,011 common shares. This amount includes 490 fully vested shares, 3,521 restricted stock units granted on November 18, 2024 that vest 25% on July 1, 2025 and annually thereafter, and 3,000 restricted stock units granted on September 16, 2025 that vest 25% on September 16, 2026 and annually thereafter. All holdings are reported as directly owned.
Ibex Limited (IBEX) reported that its Board of Directors has created a formal Nominating Committee made up entirely of independent directors. Previously, nominating duties were handled by the independent members of the full Board, a structure that the company notes already complied with Nasdaq rules requiring that director nominations be made solely by independent directors.
The new Nominating Committee will identify and evaluate director candidates, recommend nominees each year, and set criteria for board and committee membership, as outlined in its charter on the company’s website. The Board appointed Daniella Ballou-Aares as Chair, along with Karen Batungbacal, Fiona Beck, Patrick McGinnis, and Mingzhe (JJ) Zhuang, each determined to be independent under Nasdaq and SEC standards.
Upon formation, the Committee ratified prior actions of the independent directors and re-nominated the existing slate of director candidates for election at the annual meeting scheduled for December 5, 2025. These steps were taken in response to concerns raised by proxy advisory firms Institutional Shareholder Services and Glass Lewis about the nominating process, and the company believes the changes fully resolve those issues.
IBEX Ltd reported an amended insider transaction. The company’s Chief Executive Officer and Director filed a Form 4/A to record the exercise of a stock option for 45,027 common shares at $19 on 09/16/2025 (transaction code M). The filing shows 0 derivative securities remaining afterward, indicating this option position was fully exercised.
The amendment explains that the acquisition and sale of the shares underlying this option were previously reported on September 17, 2025, and the option exercise itself was inadvertently omitted and is now included. The option was fully vested and exercisable, with an expiration date of 08/07/2030. Ownership is listed as Direct.
IBEX Ltd reported an insider equity award. The company’s Chief Technology Officer filed a Form 4 for a grant of 15,000 Restricted Stock Units (RSUs) on November 11, 2025. Each RSU converts into one common share. The filing lists the acquisition at $0 and shows 15,000 shares beneficially owned directly after the transaction.
The RSUs vest over four years: 3,750 units on November 11, 2026, with an additional 3,750 units vesting annually thereafter, subject to continued service.